NPCE vs NMTC โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
NPCE Captures Institutional Edge (3โ1 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Neuropace, Inc. Common Stock (NPCE) driven by superior Valuation, Growth & Margin, Momentum & Technical while NMTC counters with relative strength in Options & Structure. Fundamentally, NPCE trades at 91.7x Forward P/E with -9.6% operating margin (-1.1% YoY revenue) versus NMTC at N/M Forward P/E and -63.4% operating margin (+16.3% YoY). In options structure, NPCE sits in BREAKDOWN (10th %ile IV; Dealer Gamma Walls on Pro) against NMTC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | NPCE Revenue | NMTC Revenue | NPCE Op. Margin | NMTC Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2013 | N/A | $0M | N/A | -2009.0% | NMTC |
| FY2014 | N/A | $0M | N/A | -4646.1% | NMTC |
| FY2020 | $40M | N/A | -31.7% | N/A | NPCE |
| FY2021 | $50M | $0M | -52.5% | -5735.9% | NPCE |
| FY2022 | $50M | $0M | -89.6% | -5860.2% | NPCE |
| FY2023 | $70M | $0M | -41.5% | -612.3% | NPCE |
| FY2024 | $80M | $0M | -27.1% | -344.3% | NPCE |
| FY2025 | $100M | $10M | -16.3% | -46.5% | NPCE |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | NPCE | NMTC | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $280.4M | $6.1M | Larger Scale | NPCE |
| Trailing P/E Ratio Valuation | 91.7x | N/M | Lower Multiple | NPCE |
| Forward P/E Ratio Valuation | 91.7x | N/M | Lower Multiple | NPCE |
| Revenue Growth (YoY) Growth | -1.1% | +16.3% | Higher Growth | NMTC |
| Operating Margin (TTM) Profitability | -9.6% | -63.4% | Higher Margin | NPCE |
| Net Profit Margin Profitability | -17.7% | -59.7% | Higher Margin | NPCE |
| Return on Equity (ROE) Capital Efficiency | -97.0% | -124.7% | Higher ROE | NPCE |
| 52-Week Range Position Momentum | 18% ($5โ$20) | 2% ($1โ$5) | Stronger Trend | NPCE |
| Beta / 30D Volatility Risk Regime | 1.17ฮฒ ยท 135% Vol | 1.55ฮฒ ยท 105% Vol | Lower Realized Risk | NMTC |
| Unified Institutional Score Composite Signal | 54.4 / 100 (HOLD) | 45.5 / 100 (HOLD) | Higher Composite | NPCE |